Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes

Nanomedicine

Volumn 8, Issue 8, 2013, Pages 1295-1305

  Kamble, Bhagyashree ^a   Talreja, Seema ^a   Gupta, Ankur ^a   Patil, Dada ^b   Pathak, Deepa ^a   Moothedath, Ismail ^a   Duraiswamy, Basavan ^a  

^a JSS COLLEGE OF PHARMACY   (India)

^b SYMBIOSIS INTERNATIONAL DEEMED UNIVERSITY   (India)

Author keywords

alloxan; antidiabetic; Gymnema sylvestre; niosomes; oral glucose tolerance test

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; NIOSOME; NONIONIC SURFACTANT;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EVALUATION STUDY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; MALE; METHODOLOGY; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; SURFACE PROPERTY; THIN FILM HYDRATION METHOD; ZETA POTENTIAL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLUCOSE TOLERANCE TEST; GYMNEMA SYLVESTRE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; LIPOSOMES; PARTICLE SIZE; PLANT EXTRACTS; RATS; SURFACE-ACTIVE AGENTS;

EID: 84893170967     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.162     Document Type: Article

References (32)

1. Saraf SA. Applications of novel drug delivery system for herbal formulations. Fitoterapia 81, 680-689 (2010
2. Yanyu X, Yunmei S, Zhipeng C, Quineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 307, 77-82 (2006
3. EL-Ridy MS, Badawi AA, Safar MM, Mohsen AM. Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug sylimarin. Int. J. Pharm. Pharmaceutical Sci. 4(1), 549-559 (2012
4. Goyal C, Ahuja M, Sharma S. Preparation and evaluation of antiinflammatory activity of Gugulipid loaded proniosomal gel. Acta Poloniae Pharma. Drug Res. 68(1), 147-150 (2011
5. Buraphacheep JV, Pratyawadee S, Suksiriworapong J, Chantasart D. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int. J. Pharm. 423, 303-311 (2012
6. Lorena T, Pasquale A, Muzzalupo R, Cindio BD. Niosomes vs microemulsions: New carriers for topical delivery of capsaicin. Colloids Surf. B Biointerfaces 87, 333-339 (2011
7. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 244, 73-80 (2002
8. Paola P, Muzzalupo R, Trombino S, Valdannini A, Nevio P. Solubilization and stabilization of b-carotene in niosomes: Delivery to cultured cells. Chem. Phy. Lipids 139, 32-42 (2006
9. Indian Pharmacopoeia Commission. Indian Pharmacopoeia (Volume 3). Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, India, 2036-2037 (2007
10. Kanetkar P, Singhal R, Kamat M. Gymnema sylvestre: A memoir. J. Clin. Biochem. Nutr. 41(2), 77-81 (2007
11. Rachh PR, Rachh MR, Ghadiya NR, Modi DC, Patel NM, Rupareliya MT. Antihyperlipidimic activity of Gymnema sylvestre leaf extract on rats fed with high cholesterol diet. Int. J. Pharmacol. 6(2), 138-141 (2010
12. Srikanth AV, Maricar S, Narsu ML, Kumar PR, Reddy M. Anticancer activity of Gymnema sylvestre R. Br. Int. J. Pharm. Sci. Nanotech. 3(1), 897-899 (2010
13. Shanmugasundaran ERB, Rajeswari G, Baskaran K, Kumar BRR, Shanmugasundaram KR, Ahmath BK. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin dependent diabetes mellitus. J. Ethnopharmacol. 30, 281-294 (1990
14. Baskaran K, Ahamath BK, Shanmugasundaram KR, Shanmugasundaram ERB. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin dependent diabetes mellitus patients. J. Ethnopharmacol. 30, 295-305 (1990
15. Yomiko N, Yukari T, Yasuhide T, Tadashi S. Fecal steroid excretion is increased in rats by oral administration of gymnemic acids contained in Gymnema sylvestre leaves. Nutr. Intract. Toxicol. 129, 1214-222 (1999
16. Ravichandran R. Physico-chemical evaluation of gymnemic acids nanocrystals. Int. J. Nanoparticles 3(3), 280-296 (2010
17. Ravichandran R. Formulation of nanosuspensions of gymnemic acids for oral administration. Int. J. Nanoparticles 3(4), 309-325 (2010
18. Arora S, Prashar B, Dhamija H, Chandel A, Thakur V. Niosomes: The unique vesicular drug carriers. J. Drug Delivery Therapeutics 2(1), 1-6 (2012
19. Kamble B, Gupta A, Patil D, Janrao S, Khatal L, Duraiswamy B. Quantitative estimation of gymnemagenin in Gymnema sylvestre extract and its marketed formulations using the HPLC-ESI-MS/MS method. Phytochem. Anal. doi:10.1002/pca.2392 (2012) (Epub ahead of print
20. Baillie AJ, Florence AT, Huma LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes-non-ionic surfactant vesicles. J. Pharm. Pharmacol. 37, 863-868 (1985
21. Li L, Gifford F, Matthew E, Ricardo C, Brian P. Technical evaluation of a fiber-optic probe dissolution system. Dissol. Tech., 15(1), 10-20 (2008
22. Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int. J. Pharm. 35, 189-198 (2008
23. Raju V, Murthy KVR. Development and validation of new discriminative dissolution method for carvedilol tablets. Indian J. Pharm. 73(5), 527-536 (2011
24. Mathew ST, Gayathri SD, Sandhya KV. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration. AAPS PharmSciTech. 8(1), E100-E108 (2007
25. ICH Topic Q 1 A (R2) Stability Testing of New Drug Substances and Products, CPMP/ ICH/2736/99. European Medicines Agency, London, UK (2003
26. Mall GK, Mishra PK, Veeru P. Antidiabetic and hypolipidemic activity of Gymnema sylvestre in alloxan induced diabetic rats. Global J. Biotech. Biochem. 4(1), 37-42 (2009
27. Nnamani PO, Attama AA, Ibezim EC, Adikwu MU. SRMS142-based solid lipid microparticles: Application in oral delivery of glibenclamide to diabetic rats. Eur. J. Pharm. Biopharm. 76, 68-74 (2010
28. Prakash RI, Lokhande SJ, Verma PR, Arora SK, Sahu RA, Patil AT. Antidiabetic potential of unripe Carissa carandas Linn. fruit extract. J. Ethnopharmacol. 135, 430-433 (2011
29. Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J. Pharm. 4(4), 227-233 (2010
30. Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech 9(3), 851-859 (2008
31. Katsuaki A, Rieko I, Soichi M et al. Three-dimensional structure of gurmarin, a sweet suppressing polypeptide. J. Biomol. NMR 5(3), 297-305 (1995
32. Sjogren H, Ericsson CA, Evenas J, Ulvenlund S. Interactions between charged polypeptides and nonionic surfactants. Biophys. J. 89, 4219-4233 (2005